Michael Holfinger, Ph.D., has been promoted to vice president of manufacturing and CMC development at Affymax, Inc. Dr. Holfinger has more than 20 years of experience in global manufacturing services for pharmaceutical and biotechnology companies. He joined the company in 2006 as director of process development and manufacturing.
 
“During his tenure at Affymax, Mike has shown impressive leadership skills and made significant contributions to our process and manufacturing development program for Omontys,” said John Orwin, chief executive officer of Affymax. “Looking ahead, his proven track record of overseeing complex commercial production at a global level and his intimate familiarity with the manufacturing process we have developed with our partner, Takeda, will be essential as we increase commercial production.”
 
Prior to joining Affymax, Dr. Holfinger held multiple roles at Pfizer, most recently as senior manager in the API support team, and held multiple positions within the chemical process R&D group at Pharmacia.